Triage Tox Drug Screen
Colorimetry, Acetaminophen. 510(k) K043242, from Biosite Incorporated (San Diego, CA). Product code LDP, class 2.
As of Nov 20, 2026, K043242 is an FDA 510(k) held by Biosite Incorporated, substantially equivalent on Feb 28, 2005 after 97 days, with 1 recall tied to it in FDA's recall database.
- Review time: 97 days
- Recalls: 1
- Cited as a predicate by: 3 devices
The Triage$^{®}$ TOX Drug Screen is a fluorescence immunoassay intended to be used with the Triage MeterPlus for the point-of-care qualitative determination of the presence of major metabolites above the threshold concentrations of up to 8 distinct drug classes, including assays for acetaminophen/paracetamol, amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, opiates…
- Quidel Triage TOX Drug Screen, 94600; Quidel Triage® MeterProK182719 · Quidel Cardiovascular, Inc. · Jun 19, 2019
- Uniscan -Doa SystemK080347 · Taiwan Unison Biotech, Inc. · Oct 9, 2008
- Triage Tox Drug Screen, Model 94400K060791 · Biosite Incorporated · Jun 22, 2006
| Started | Recall | Status |
|---|---|---|
| Jul 12, 2012 | Z-2460-2012Alere San Diego is recalling Alere Triage TOX Drug Screen because there is a possibility that after installing the code chip provided with the affected lots: AMP, BAR, and PCP, the threshold ranges may not be… | Terminated |
- Atellica CH Acetaminophen 2 (ACTM)K261364 · Siemens Healthcare Diagnostics, Inc. · Jul 24, 2026
- AcetaminophenK202644 · Sekisui Diagnostics P.E.I., Inc. · Feb 18, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 23, 2004
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3030
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files